94279 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitrogen atoms
Substituted naphthalene sulfonamides
#602New compounds
#603Compounds
#604Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
#605c-Met modulators and methods of use
#606Aryl nitrogen-containing bicyclic compounds and methods of use
#6072-Adamantyl derivatives as p2X7 receptor antagonists.
#608Antiviral agents
#609Use of a compound of formula 1 for making a pharmaceutical composition
#610Novel compounds of amino sulfonyl derivatives
#611NPY Y5 antagonist
#612Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
#613Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#614Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#615P2Xreceptor antagonists and their use
#616L-Threonine derivatives of high therapeutic index
#617Non-symmetrical gelling agent
#618Acylhydrazine P2X7 antagonists and uses thereof
#619Compounds useful for DPP-IV enzyme inhibition
#6203-methanesulfonylquinolines as GABAenhancers
#621Ether derivative
#622Method of preparing 3-cyano-quinolines and intermediates made thereby
#623Mchir antagonists
#624Nitrogen-containing aromatic derivatives
#625Cyclopentapyridine and tetrahydroquinoline derivatives
#626Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications
#627Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#628Compounds and methods of use
#629Compounds with high therapeutic index
#630Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same
#631Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#632Compounds
#633Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#634Chemical derivatives and their application as antitelomerase agent
#635Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#636Sulfonamide inhibitors of aspartyl protease
#637Method for the synthesis of quinoline derivatives
#638Sulfonamide derivatives of polycyclic dyes used for analytical applications
#639Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
#6401-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
#641Tetrahydroquinoline derivatives and their use as FSH receptor modulators
#642Bicyclic heterocycles as cannabinoid receptor modulators
#643Nitrogen-containing aromatic derivatives
#644Fluorescent lanthadine complex
#645Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
#646Tetrahydroquinoline derivatives
#647Vanilloid receptor modulators
#648Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups
#649Heterocyclic and bicyclic compounds, compositions and methods
#650Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
#651Phosphodiesterase inhibitor
#652Production of small particles
#653Quinolines as allosteric enhancers of the GABAreceptors
#6548-hydroxy quinoline derivatives
#655Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents
#656Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
#657Modulators of ATP-binding cassette transporters
#658Compounds for the treatment of inflammatory disorders
#659Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#660Mercaptoamides as histone deacetylase inhibitors
#661Vanilloid receptor ligands and their use in treatments
#662Amide derivatives and nociceptin antagonists
#663Hybrid 2-aminoterailin and aryl-substituted piperazine compounds and their use in altering CNS activity
#664Sulfonylamino-acetic acid derivatives
#665N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
#666Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#667Bicyclic androgen and progesterone receptor modulator compounds and methods
#668Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#669Vanilloid receptor ligands and their use in treatments
#670Vanilloid receptor ligands and their use in treatments
#671Vanilloid receptor ligands and their use in treatments
#672Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#673Vanilloid receptor ligands and their use in treatments
#674Novel piperidine and piperazine derivatives
#6752-amino- and 2-thio- substituted 1,3-diaminopropanes
#676Serine protease inhibitors
#677Vanilloid receptor ligands and their use in treatments
#678Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
#679Hydrazide-containing CFTR inhibitor compounds and uses thereof
#68011β-hydroxysteroid dehydrogenase inhibitors
#681Vanilloid receptor ligands and their use in treatments
#682Process for the preparation of 4-methyl-7-aminoquinolones
#683Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
#684Nitrogen heterocycle biaryls for osteoporosis and other diseases
#685Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#686Serine protease inhibitors
#687Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#688Metabotropic glutamate receptor antagonists
#689Quinoline compound
#690Glucagon antagonists/inverse agonists
#691Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#692Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#693Process for preparing 3-fluoroquinolines
#694Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
#695Integrin expression inhibitor
#696Method for the synthesis of quinoline derivatives
#697Modulators of the glucocorticoid receptor and method
#698Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#699Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
#700Vanilloid receptor ligands and their use in treatments
#701Vanilloid receptor ligands and their use in treatments
#702Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
#703Substituted pentanols, a process for their production and their use as anti-inflammatory agents
#704Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
#705Compounds and methods of use
#706Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
#707Amino-substituted ethylamino βadrenergic receptor agonists
#708Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain
#709Antipruritics
#710Novel adamantane derivatives
#711Therapeutic morpholino-substituted compounds
#712Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
#713Piperazine derivatives
#714Diamine derivatives of quinone and uses thereof
#715Compounds
#716Tetrahydroquinoline derivatives as cannabinoid receptor modulators
#717Tetrahydroquinoline derivatives as cannabinoid receptor modulators
#718Sulfonamide derivatives
#719Tetrahydroquinoline derivatives and a process of preparation thereof